Matthew D. Robson

Matthew D. Robson

Auto-generated profile, based on publicly available information

Matthew D. Robson

Oxford Centre for Clinical Magnetic Resonance Research, Radcliffe Department of Medicine University of Oxford Oxford UK

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2005 in JACC
Verified
Journal Article
Closed access
SPSteffen Petersen
Steffen Petersen
JSJoseph B. Selvanayagam
Joseph B. Selvanayagam
FWFrank Wiesmann
Frank Wiesmann
MRMatthew D. Robson
Matthew D. Robson
JFJane M. Francis
Jane M. Francis
SNStefan Neubauer
Stefan Neubauer

1 January 2013 in Journal of Cardiovascular Magnetic Resonance
Verified
Journal Article
Open access
PDF file
JMJames C Moon
James C Moon
DMDaniel R Messroghli
Daniel R Messroghli
PKPeter Kellman
Peter Kellman
SPStefan K Piechnik
Stefan K Piechnik
MRMatthew D Robson
Matthew D Robson
ESErik B Schelbert
Erik B Schelbert
Rapid innovations in cardiovascular magnetic resonance (CMR) now permit the routine acquisition of quantitative measures of myocardial and blood T1 which are key tissue characteristics. These capabilities introduce a new frontier in cardiology, enabling the practitioner/investigator to quantify biologically important myocardial properties that otherwise can be difficult to ascertain clinically. CMR may be able to track biologically important changes in the myocardium by: a) native T1 that reflects myocardial disease involving the myocyte and interstitium without use of gadolinium based contrast agents (GBCA), or b) the extracellular volume fraction (ECV)–a direct GBCA-based measurement of the size of the extracellular space, reflecting interstitial disease. The latter technique attempts to dichotomize the myocardium into its cellular and interstitial components with estimates expressed as volume fractions. This document provides recommendations for clinical and research T1 and ECV measurement, based on published evidence when available and expert consensus when not. We address site preparation, scan type, scan planning and acquisition, quality control, visualisation and analysis, technical development. We also address controversies in the field. While ECV and native T1 mapping appear destined to affect clinical decision making, they lack multi-centre application and face significant challenges, which demand a community-wide approach among stakeholders. At present, ECV and native T1 mapping appear sufficiently robust for many diseases; yet more research is required before a large-scale application for clinical decision-making can be recommended.

30 August 2004 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
HJH. Johansen-Berg
H. Johansen-Berg
TBT. E. J. Behrens
T. E. J. Behrens
MRM. D. Robson
M. D. Robson
IDI. Drobnjak
I. Drobnjak
MRM. F. S. Rushworth
M. F. S. Rushworth
PMP. M. Matthews
P. M. Matthews
A fundamental issue in neuroscience is the relation between structure and function. However, gross landmarks do not correspond well to microstructural borders and cytoarchitecture cannot be visualized in a living brain used for functional studies. Here, we used diffusion-weighted and functional MRI to test structure-function relations directly. Distinct neocortical regions were defined as volumes having similar connectivity profiles and borders identified where connectivity changed. Without using prior information, we found an abrupt profile change where the border between supplementary motor area (SMA) and pre-SMA is expected. Consistent with this anatomical assignment, putative SMA and pre-SMA connected to motor and prefrontal regions, respectively. Excellent spatial correlations were found between volumes defined by using connectivity alone and volumes activated during tasks designed to involve SMA or pre-SMA selectively. This finding demonstrates a strong relationship between structure and function in medial frontal cortex and offers a strategy for testing such correspondences elsewhere in the brain.

1 November 2003 in Journal of Computer Assisted Tomography
Verified
Journal Article
Closed access
MRMatthew D. Robson
Matthew D. Robson
PGPeter D. Gatehouse
Peter D. Gatehouse
MBMark Bydder
Mark Bydder
GBGraeme M. Bydder
Graeme M. Bydder
The background underpinning the clinical use of ultrashort echo-time (UTE) pulse sequences for imaging tissues or tissue components with short T2s is reviewed. Tissues properties are discussed, and tissues are divided into those with a majority of short T2 relaxation components and those with a minority. Features of the basic physics relevant to UTE imaging are described including the fact that when the radiofrequency pulse duration is of the order T2, rotation of tissue magnetization into the transverse plane is incomplete. Consequences of the broad line-width of short T2 components are also discussed including their partial saturation by off-resonance fat suppression pulses as well as multislice and multiecho imaging. The need for rapid data acquisition of the order T2 is explained. The basic UTE pulse sequence with its half excitation pulse and radial imaging from the center of k-space is described together with options that suppress fat and/or long T2 components. Image interpretation is discussed. Clinical features of the imaging of cortical bone, tendons, ligaments, menisci, and periosteum as well as brain, liver, and spine are illustrated. Short T2 components in all of these tissues may show high signals. Possible future developments are outlined as are technical limitations.

1 October 2010 in Journal of Cardiovascular Magnetic Resonance
Verified
Journal Article
Open access
PDF file
SPStefan K Piechnik
Stefan K Piechnik
VFVanessa M Ferreira
Vanessa M Ferreira
EDErica Dall'ARmellina
Erica Dall'ARmellina
LCLowri E Cochlin
Lowri E Cochlin
AGAndreas Greiser
Andreas Greiser
MRMatthew D Robson
Matthew D Robson
T1 mapping allows direct in-vivo quantitation of microscopic changes in the myocardium, providing new diagnostic insights into cardiac disease. Existing methods require long breath holds that are demanding for many cardiac patients. In this work we propose and validate a novel, clinically applicable, pulse sequence for myocardial T1-mapping that is compatible with typical limits for end-expiration breath-holding in patients. The Shortened MOdified Look-Locker Inversion recovery (ShMOLLI) method uses sequential inversion recovery measurements within a single short breath-hold. Full recovery of the longitudinal magnetisation between sequential inversion pulses is not achieved, but conditional interpretation of samples for reconstruction of T1-maps is used to yield accurate measurements, and this algorithm is implemented directly on the scanner. We performed computer simulations for 100 ms<T1 < 2.7 s and heart rates 40-100 bpm followed by phantom validation at 1.5T and 3T. In-vivo myocardial T1-mapping using this method and the previous gold-standard (MOLLI) was performed in 10 healthy volunteers at 1.5T and 3T, 4 volunteers with contrast injection at 1.5T, and 4 patients with recent myocardial infarction (MI) at 3T. We found good agreement between the average ShMOLLI and MOLLI estimates for T1 < 1200 ms. In contrast to the original method, ShMOLLI showed no dependence on heart rates for long T1 values, with estimates characterized by a constant 4% underestimation for T1 = 800-2700 ms. In-vivo, ShMOLLI measurements required 9.0 ± 1.1 s (MOLLI = 17.6 ± 2.9 s). Average healthy myocardial T1 s by ShMOLLI at 1.5T were 966 ± 48 ms (mean ± SD) and 1166 ± 60 ms at 3T. In MI patients, the T1 in unaffected myocardium (1216 ± 42 ms) was similar to controls at 3T. Ischemically injured myocardium showed increased T1 = 1432 ± 33 ms (p < 0.001). The difference between MI and remote myocardium was estimated 15% larger by ShMOLLI than MOLLI (p < 0.04) which suffers from heart rate dependencies for long T1. The in-vivo variability within ShMOLLI T1-maps was only 14% (1.5T) or 18% (3T) higher than the MOLLI maps, but the MOLLI acquisitions were twice longer than ShMOLLI acquisitions. ShMOLLI is an efficient method that generates immediate, high-resolution myocardial T1-maps in a short breath-hold with high precision. This technique provides a valuable clinically applicable tool for myocardial tissue characterisation.

1 April 2013 in JACC: Cardiovascular Imaging
Verified
Journal Article
Closed access
Theodoros D. KaramitsosTheodoros D. Karamitsos
Theodoros D. Karamitsos
SPStefan K. Piechnik
Stefan K. Piechnik
SBSanjay M. Banypersad
Sanjay M. Banypersad
MFMarianna Fontana
Marianna Fontana
NNNtobeko Ntusi
Ntobeko Ntusi
JMJames C. Moon
James C. Moon